<!DOCTYPE html><html><head><link rel="icon" href="/favicon.ico"/><link href="/assets/fonts/fonts.css" rel="stylesheet"/><meta name="theme-color" content="#0E4981"/><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin /><meta charSet="utf-8"/><meta name="viewport" content="width=device-width"/><meta name="next-head-count" content="2"/><link rel="preload" href="/_next/static/css/43ace0b7a831dd0e.css" as="style"/><link rel="stylesheet" href="/_next/static/css/43ace0b7a831dd0e.css" data-n-g=""/><noscript data-n-css=""></noscript><script defer="" nomodule="" src="/_next/static/chunks/polyfills-5cd94c89d3acac5f.js"></script><script src="/_next/static/chunks/webpack-f8fe1f0eb2299c5d.js" defer=""></script><script src="/_next/static/chunks/framework-b2b803b7657b42a9.js" defer=""></script><script src="/_next/static/chunks/main-d3f8c9f19d92620b.js" defer=""></script><script src="/_next/static/chunks/pages/_app-e547a556ef7a4fab.js" defer=""></script><script src="/_next/static/chunks/pages/research/research-programs/integrated-head-and-neck-oncology-e3e0b199a5d651bb.js" defer=""></script><script src="/_next/static/c1L5CVtJO_lyp2yG3iKVw/_buildManifest.js" defer=""></script><script src="/_next/static/c1L5CVtJO_lyp2yG3iKVw/_ssgManifest.js" defer=""></script><script src="/_next/static/c1L5CVtJO_lyp2yG3iKVw/_middlewareManifest.js" defer=""></script><style data-href="https://fonts.googleapis.com/css?family=Material+Icons|Material+Icons+Outlined|Material+Icons+Two+Tone|Material+Icons+Round|Material+Icons+Sharp">@font-face{font-family:'Material Icons';font-style:normal;font-weight:400;src:url(https://fonts.gstatic.com/s/materialicons/v125/flUhRq6tzZclQEJ-Vdg-IuiaDsNa.woff) format('woff')}@font-face{font-family:'Material Icons Outlined';font-style:normal;font-weight:400;src:url(https://fonts.gstatic.com/s/materialiconsoutlined/v100/gok-H7zzDkdnRel8-DQ6KAXJ69wP1tGnf4ZGhUcY.woff) format('woff')}@font-face{font-family:'Material Icons Round';font-style:normal;font-weight:400;src:url(https://fonts.gstatic.com/s/materialiconsround/v99/LDItaoyNOAY6Uewc665JcIzCKsKc_M9flwmJ.woff) format('woff')}@font-face{font-family:'Material Icons Sharp';font-style:normal;font-weight:400;src:url(https://fonts.gstatic.com/s/materialiconssharp/v100/oPWQ_lt5nv4pWNJpghLP75WiFR4kLh3kvmvX.woff) format('woff')}@font-face{font-family:'Material Icons Two Tone';font-style:normal;font-weight:400;src:url(https://fonts.gstatic.com/s/materialiconstwotone/v103/hESh6WRmNCxEqUmNyh3JDeGxjVVyMg4tHGctNCuy.woff) format('woff')}.material-icons{font-family:'Material Icons';font-weight:normal;font-style:normal;font-size:24px;line-height:1;letter-spacing:normal;text-transform:none;display:inline-block;white-space:nowrap;word-wrap:normal;direction:ltr;font-feature-settings:'liga'}.material-icons-outlined{font-family:'Material Icons Outlined';font-weight:normal;font-style:normal;font-size:24px;line-height:1;letter-spacing:normal;text-transform:none;display:inline-block;white-space:nowrap;word-wrap:normal;direction:ltr;font-feature-settings:'liga'}.material-icons-round{font-family:'Material Icons Round';font-weight:normal;font-style:normal;font-size:24px;line-height:1;letter-spacing:normal;text-transform:none;display:inline-block;white-space:nowrap;word-wrap:normal;direction:ltr;font-feature-settings:'liga'}.material-icons-sharp{font-family:'Material Icons Sharp';font-weight:normal;font-style:normal;font-size:24px;line-height:1;letter-spacing:normal;text-transform:none;display:inline-block;white-space:nowrap;word-wrap:normal;direction:ltr;font-feature-settings:'liga'}.material-icons-two-tone{font-family:'Material Icons Two Tone';font-weight:normal;font-style:normal;font-size:24px;line-height:1;letter-spacing:normal;text-transform:none;display:inline-block;white-space:nowrap;word-wrap:normal;direction:ltr;font-feature-settings:'liga'}@font-face{font-family:'Material Icons';font-style:normal;font-weight:400;src:url(https://fonts.gstatic.com/s/materialicons/v125/flUhRq6tzZclQEJ-Vdg-IuiaDsNcIhQ8tQ.woff2) format('woff2')}@font-face{font-family:'Material Icons Outlined';font-style:normal;font-weight:400;src:url(https://fonts.gstatic.com/s/materialiconsoutlined/v100/gok-H7zzDkdnRel8-DQ6KAXJ69wP1tGnf4ZGhUcel5euIg.woff2) format('woff2')}@font-face{font-family:'Material Icons Round';font-style:normal;font-weight:400;src:url(https://fonts.gstatic.com/s/materialiconsround/v99/LDItaoyNOAY6Uewc665JcIzCKsKc_M9flwmPq_HTTw.woff2) format('woff2')}@font-face{font-family:'Material Icons Sharp';font-style:normal;font-weight:400;src:url(https://fonts.gstatic.com/s/materialiconssharp/v100/oPWQ_lt5nv4pWNJpghLP75WiFR4kLh3kvmvRImcycg.woff2) format('woff2')}@font-face{font-family:'Material Icons Two Tone';font-style:normal;font-weight:400;src:url(https://fonts.gstatic.com/s/materialiconstwotone/v103/hESh6WRmNCxEqUmNyh3JDeGxjVVyMg4tHGctNCu0NjbrHg.woff2) format('woff2')}.material-icons{font-family:'Material Icons';font-weight:normal;font-style:normal;font-size:24px;line-height:1;letter-spacing:normal;text-transform:none;display:inline-block;white-space:nowrap;word-wrap:normal;direction:ltr;-webkit-font-feature-settings:'liga';-webkit-font-smoothing:antialiased}.material-icons-outlined{font-family:'Material Icons Outlined';font-weight:normal;font-style:normal;font-size:24px;line-height:1;letter-spacing:normal;text-transform:none;display:inline-block;white-space:nowrap;word-wrap:normal;direction:ltr;-webkit-font-feature-settings:'liga';-webkit-font-smoothing:antialiased}.material-icons-round{font-family:'Material Icons Round';font-weight:normal;font-style:normal;font-size:24px;line-height:1;letter-spacing:normal;text-transform:none;display:inline-block;white-space:nowrap;word-wrap:normal;direction:ltr;-webkit-font-feature-settings:'liga';-webkit-font-smoothing:antialiased}.material-icons-sharp{font-family:'Material Icons Sharp';font-weight:normal;font-style:normal;font-size:24px;line-height:1;letter-spacing:normal;text-transform:none;display:inline-block;white-space:nowrap;word-wrap:normal;direction:ltr;-webkit-font-feature-settings:'liga';-webkit-font-smoothing:antialiased}.material-icons-two-tone{font-family:'Material Icons Two Tone';font-weight:normal;font-style:normal;font-size:24px;line-height:1;letter-spacing:normal;text-transform:none;display:inline-block;white-space:nowrap;word-wrap:normal;direction:ltr;-webkit-font-feature-settings:'liga';-webkit-font-smoothing:antialiased}</style></head><body><div id="__next"><div><nav class="msmf__nav-top msmf__nav-bar"><div id="msmf-branding" class="cursor-pointer"><img src="/assets/msmf_logo1.jpg" alt="msmf-logo" class=" w-44 min-w-[11rem]"/></div><div class="msmf__nav-list"><p class="relative msmf__nav-item  font-helvetica font-bold flex items-center "><span>Incubation</span></p><p class="relative msmf__nav-item  font-helvetica font-bold flex items-center "><span>ADRC</span></p><p class="relative msmf__nav-item  font-helvetica font-bold flex items-center "><span>Philanthropy</span></p><p class="relative msmf__nav-item  font-helvetica font-bold flex items-center "><span>Research</span></p></div></nav><section class="mt-32 w-full"><div class="w-10/12 mx-auto"><div class="prose max-w-full text-justify"><div class="msmf__content-card border-msmf-base"><p class="text-2xl font-bold text-[#6A6A6A] m-0 uppercase">Research Programs</p><p class="text-4xl font-bold uppercase my-3">Integrated Head and Neck Oncology</p><p>Head and neck cancer is the sixth most common cancer around the world and the leading form of cancer in the Asian subcontinent. The Integrated Head and Neck Oncology Research Program at MSCTR attempts to address two grand challenges in head and neck oncology:<!-- --> <ol type="a"><li>Can we down-stage oral cancer?</li><li>Could we reverse treatment resistance in head and neck cancer?</li></ol><br/>Over two-thirds of the patients with head and neck cancer represents advanced stages III/IV, with an overall survival rate of less than 20%. It has been demonstrated that while the outcome of advanced head and neck cancer in India is about 25% below that of developed nations, the survival outcome of early stage cancer that require single modality treatment is about 80%, which is comparable with that of the developed nations. The primary focus of our research group is hence to understand oral carcinogenesis and develop affordable strategies for early detection and introduce detours in the carcinogenic process.About 50% of all head and neck cancers recur after ‘curative intent treatment’. As in majority of solid tumours, once the disease recurs or develops distant metastasis, there are no curative treatment options. The second focus of our research group is to understand mechanisms of treatment resistance and to develop effective methods for detecting disease relapse and to treat the recurrent and metastatic disease with the ultimate goal of ‘molecular pathway’ based adaptive personalized therapy for patients with head and neck cancer. In an effort to establish an efficient research program and to enable effective translation of the scientific discoveries for clinical benefit, the research program is integrated with the Department of Head and Neck Surgery, Mazumdar-Shaw Medical Center and has initiated collaborations with national and international institutions that offer complementary expertise. <br/><br/>The program adopts two major approaches to address the clinical challenges<!-- --> <ol type="a"><li>A systems biology approach: exploring the whole genome, transcriptome, methylome and proteome as well as the status of targeted markers in tissues, and body fluids, such as saliva and blood</li><li>A &#x27;cancer stem cell&#x27; perspective: exploring the role of CSCs in the process of tumorigenesis, field cancerization, drug resistance and metastasis</li></ol>The major ongoing research programs of the group are:<!-- --> <ol type="a"><li>Smart-phone based outreach program for screening and early detection; Imaging and molecular cytology based methods for point of care screening</li><li>Salivary biomarkers for the early detection of oral cancer</li><li>Integrated ómics approach to predict treatment outcome prediction in oral potentially malignant lesions, laryngo-pharyngeal cancers</li><li>Cancer Stem Cells (CSC) in field cancerization and tumorigenesis of oral cancer</li><li>Role of CSCs in drug resistance with resistant cell lines as a model</li><li>Development of 3D systems that mimic the TME in HNSCC as models to predict treatment outcome</li><li>Markers of nodal metastasis and PoC assays for intra-operative detection of nodal metastasis</li></ol></p></div><div class=" bg-msmf-dark flex items-center justify-between px-4 w-full"><div id="content" class="w-7/12 px-8 py-8"><p class="uppercase font-bold text-research">Principal Investigator</p><p class="text-white font-semibold text-4xl">Amritha Suresh, Principal Investigator, PhD (Molecular Biology)</p><p class="text-2xl text-white">Dr. Amritha Suresh is a Principal Scientist of the Integrated Head and Neck Oncology Program, at Mazumdar Shaw Center for Translational Research (MSCTR), Narayana Health, Bangalore. She is also a faculty of the Roswell Park-Mazumdar Shaw Medical Foundation Collaborative Research program. Dr. Suresh completed her doctoral program from Center for Cellular and Molecular Biology (JNU) and served as a Research Associate at Head and Neck Institute, Amrita Institute of Medical Sciences and Research Center, Kochi during which period she was involved in setting up the research facility and the establishment of a Head and Neck tissue repository at the center.</p></div><div id="image" class="w-5/12 px-4 flex justify-center flex-col items-center"><img src="/assets/images/Research/Rectangle 1470.png" alt="Manjula Das"/><p class="m-0 text-white text-xl">manjula.das@ms-mf.org</p></div></div><div class="msmf__content-card border-msmf-base"><div id="accordion"><div id="accordion-header" class="flex justify-between items-center cursor-pointer w-full"><div class="w-10/12"><p class="m-0 mt-4 text-xl font-bold text-[#6A6A6A] uppercase">Research Project</p><p class="m-0 mt-2 mb-4 text-4xl font-semibold ">Development of Comprehensive Pre-Cancer Genome/Transcriptome Atlas (CPCGA) of oral cavity</p></div><button type="button" class="w-1/12"><span class="transition duration-300 ease-in-out text-6xl material-icons-round false">arrow_drop_down</span></button></div><p>Inregrated molecular Atlas for OPMD, Markers for malignant transformation, targets for chemoprevention.</p></div></div><div class="msmf__content-card border-msmf-base"><div id="accordion"><div id="accordion-header" class="flex justify-between items-center cursor-pointer w-full"><div class="w-10/12"><p class="m-0 mt-4 text-xl font-bold text-[#6A6A6A] uppercase">Research Project</p><p class="m-0 mt-2 mb-4 text-4xl font-semibold ">Biomarkers for Nodal Metastasis in head and neck cancer</p></div><button type="button" class="w-1/12"><span class="transition duration-300 ease-in-out text-6xl material-icons-round false">arrow_drop_down</span></button></div><p>Biomarkers for nodal metastasis detection</p></div></div><div class="msmf__content-card border-msmf-base"><div id="accordion"><div id="accordion-header" class="flex justify-between items-center cursor-pointer w-full"><div class="w-10/12"><p class="m-0 mt-4 text-xl font-bold text-[#6A6A6A] uppercase">Research Project</p><p class="m-0 mt-2 mb-4 text-4xl font-semibold ">Curcumin and Metformin for prevention second primary tumors of aero-digestive tract in patients with history of head and neck squamous cell carcinoma </p></div><button type="button" class="w-1/12"><span class="transition duration-300 ease-in-out text-6xl material-icons-round false">arrow_drop_down</span></button></div><p>Drug combination for SPT prevention</p></div></div><div class="msmf__content-card border-msmf-base"><div id="accordion"><div id="accordion-header" class="flex justify-between items-center cursor-pointer w-full"><div class="w-10/12"><p class="m-0 mt-4 text-xl font-bold text-[#6A6A6A] uppercase">Research Project</p><p class="m-0 mt-2 mb-4 text-4xl font-semibold ">PARPCytometry-A quantitative and affordable diagnostic system for head and neck cancer diagnostics</p></div><button type="button" class="w-1/12"><span class="transition duration-300 ease-in-out text-6xl material-icons-round false">arrow_drop_down</span></button></div><p>Molecular cytology based early detection assay</p></div></div><div class="msmf__content-card border-msmf-base"><div id="accordion"><div id="accordion-header" class="flex justify-between items-center cursor-pointer w-full"><div class="w-10/12"><p class="m-0 mt-4 text-xl font-bold text-[#6A6A6A] uppercase">Research Project</p><p class="m-0 mt-2 mb-4 text-4xl font-semibold ">Cancer Stem cells in  chemoprevention</p></div><button type="button" class="w-1/12"><span class="transition duration-300 ease-in-out text-6xl material-icons-round false">arrow_drop_down</span></button></div><p>Novel markers for progression and chemoprevention</p></div></div><div class="msmf__content-card border-msmf-base"><div id="accordion"><div id="accordion-header" class="flex justify-between items-center cursor-pointer w-full"><div class="w-10/12"><p class="m-0 mt-4 text-xl font-bold text-[#6A6A6A] uppercase">Research Project</p><p class="m-0 mt-2 mb-4 text-4xl font-semibold ">Molecular prognosticators and novel targets in chemo-resistant Head and Neck Cancer</p></div><button type="button" class="w-1/12"><span class="transition duration-300 ease-in-out text-6xl material-icons-round false">arrow_drop_down</span></button></div><p>Novel markers for outcome prediction</p></div></div><div class="msmf__content-card border-msmf-base"><div id="accordion"><div id="accordion-header" class="flex justify-between items-center cursor-pointer w-full"><div class="w-10/12"><p class="m-0 mt-4 text-xl font-bold text-[#6A6A6A] uppercase">Research Project</p><p class="m-0 mt-2 mb-4 text-4xl font-semibold ">Lectin cytometry- a smart and economical diagnostic tool for Thyroid cancer.</p></div><button type="button" class="w-1/12"><span class="transition duration-300 ease-in-out text-6xl material-icons-round false">arrow_drop_down</span></button></div><p>Molecular cytology as adjunct for FNAC</p></div></div><div class="msmf__content-card border-msmf-base"><div id="accordion"><div id="accordion-header" class="flex justify-between items-center cursor-pointer w-full"><div class="w-10/12"><p class="m-0 mt-4 text-xl font-bold text-[#6A6A6A] uppercase">Research Project</p><p class="m-0 mt-2 mb-4 text-4xl font-semibold ">Development of 3D model for prediction of treatment outcome</p></div><button type="button" class="w-1/12"><span class="transition duration-300 ease-in-out text-6xl material-icons-round false">arrow_drop_down</span></button></div><p>3D model fot drug testing/treatment outcome prediction</p></div></div><div class="msmf__content-card border-msmf-base"><div id="accordion"><div id="accordion-header" class="flex justify-between items-center cursor-pointer w-full"><div class="w-10/12"><p class="m-0 mt-4 text-xl font-bold text-[#6A6A6A] uppercase">Research Project</p><p class="m-0 mt-2 mb-4 text-4xl font-semibold ">Development of salivary biomarker based PoC assay</p></div><button type="button" class="w-1/12"><span class="transition duration-300 ease-in-out text-6xl material-icons-round false">arrow_drop_down</span></button></div><p>PoC assay for screening/detection</p></div></div><div class="msmf__content-card border-msmf-base"><p class="text-2xl font-bold text-[#6A6A6A] m-0 uppercase">Publications</p><p class="text-2xl font-bold uppercase">2021</p><ol><li><p class="font-bold mb-0">Mobile-based oral cancer classification for point-of-care screening</p><p class="mt-0">Song B, Sunny S, Li S, Gurushanth K, Mendonca P, Mukhia N, Patrick S, Gurudath S, Raghavan S, Imchen T, Leivon S, Kolur T, Shetty V, Bushan V, Ramesh R, Lima N, Pillai V, Wilder-Smith P, Sigamani A, Suresh A, Kuriakose M, Birur P, Liang R. J Biomed Opt. 2021 Jun;26(6):065003. doi: 10.1117/1.JBO.26.6.065003. PMID: 34164967; PMCID: PMC8220969.</p></li><li><p class="font-bold mb-0">Validation of a Point-of-Care Optical Coherence Tomography Device with Machine Learning Algorithm for Detection of Oral Potentially Malignant and Malignant Lesions. Cancers (Basel)</p><p class="mt-0">James BL, Sunny SP, Heidari AE, Ramanjinappa RD, Lam T, Tran AV, Kankanala S, Sil S, Tiwari V, Patrick S, Pillai V, Shetty V, Hedne N, Shah D, Shah N, Chen ZP, Kandasarma U, Raghavan SA, Gurudath S, Nagaraj PB, Wilder-Smith P, Suresh A, Kuriakose MA. 2021 Jul 17;13(14):3583. doi: 10.3390/cancers13143583. PMID: 34298796; PMCID: PMC8304149.</p></li></ol><p class="text-2xl font-bold uppercase">2020</p><ol><li><p class="font-bold mb-0">Validation of the use of a fluorescent PARP1 inhibitor for the detection of oral, oropharyngeal and oesophageal epithelial cancers</p><p class="mt-0">Kossatz S, Pirovano G, Demétrio De Souza França P, Strome AL, Sunny SP, Zanoni DK, Mauguen A, Carney B, Brand C, Shah V, Ramanajinappa RD, Hedne N, Birur P, Sihag S, Ghossein RA, Gönen M, Strome M, Suresh A, Molena D, Ganly I, Kuriakose MA, Patel SG, Reiner T. Nat Biomed Eng. 2020 Mar;4(3):272-285. doi: 10.1038/s41551-020-0526-9. Epub 2020 Mar 12. PubMed PMID: 32165735; PubMed Central PMCID: PMC7136849.</p></li><li><p class="font-bold mb-0">Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection</p><p class="mt-0">Sivadasan P, Gupta MK, Sathe G, Sudheendra HV, Sunny SP, Renu D, Hari PS, Gowda H, Suresh A, Kuriakose MA, Sirdeshmukh R. J Proteomics. 2020 Feb 10;212:103574. doi: 10.1016/j.jprot.2019.103574. Epub 2019 Nov 7. PubMed PMID: 31706945.</p></li></ol><p class="text-2xl font-bold uppercase">2019</p><ol><li><p class="font-bold mb-0">A smart tele-cytology point-of-care platform for oral cancer screening</p><p class="mt-0">Sunny S, Baby A, James BL, Balaji D, N V A, Rana MH, Gurpur P, Skandarajah A, D&#x27;Ambrosio M, Ramanjinappa RD, Mohan SP, Raghavan N, Kandasarma U, N S, Raghavan S, Hedne N, Koch F, Fletcher DA, Selvam S, Kollegal M, N PB, Ladic L, Suresh A, Pandya HJ, Kuriakose MA. PLoS One. 2019;14(11):e0224885. doi: 10.1371/journal.pone.0224885. eCollection 2019. PubMed PMID: 31730638; PubMed Central PMCID: PMC6857853.</p></li><li><p class="font-bold mb-0">Small form factor, flexible, dual-modality handheld probe for smartphone-based, point-of-care oral and oropharyngeal cancer screening</p><p class="mt-0">Uthoff RD, Song B, Sunny S, Patrick S, Suresh A, Kolur T, Gurushanth K, Wooten K, Gupta V, Platek ME, Singh AK, Wilder-Smith P, Kuriakose MA, Birur P, Liang R. J Biomed Opt. 2019 Oct;24(10):1-8. doi: 10.1117/1.JBO.24.10.106003. PubMed PMID: 31642247; PubMed Central PMCID: PMC6826203.</p></li><li><p class="font-bold mb-0">Evaluation of a Lectin-Based Imaging System for the Chairside Detection of Oral Dysplasia and Malignancy</p><p class="mt-0">Johnson A, Baeten J, Patel K, Killian M, Sunny S, Suresh A, Uma K, Birur P, Kuriakose M, Kademani D. J Oral Maxillofac Surg. 2019 Sep;77(9):1941-1951. doi: 10.1016/j.joms.2019.03.012. Epub 2019 Mar 26. PubMed PMID: 31004587.</p></li><li><p class="font-bold mb-0">Molecular prognosticators in clinically and pathologically distinct cohorts of head and neck squamous cell carcinoma-A meta-analysis approach</p><p class="mt-0">Reddy RB, Khora SS, Suresh A. PLoS One. 2019;14(7):e0218989. doi: 10.1371/journal.pone.0218989. eCollection 2019. PubMed PMID: 31310629; PubMed Central PMCID: PMC6634788.</p></li><li><p class="font-bold mb-0">Cancer stem cells and fibroblast niche cross talk in an in-vitro oral dysplasia model.</p><p class="mt-0">Kulsum S, Raju N, Raghavan N, Ramanjanappa RDR, Sharma A, Mehta A, Kuriakose MA, Suresh A. Mol Carcinog. 2019 May;58(5):820-831. doi: 10.1002/mc.22974. Epub 2019 Jan 31. PubMed PMID: 30644602.</p></li><li><p class="font-bold mb-0">Intra-operative point-of-procedure delineation of oral cancer margins using optical coherence tomography</p><p class="mt-0">Sunny SP, Agarwal S, James BL, Heidari E, Muralidharan A, Yadav V, Pillai V, Shetty V, Chen Z, Hedne N, Wilder-Smith P, Suresh A, Kuriakose MA. Oral Oncol. 2019 May;92:12-19. doi: 10.1016/j.oraloncology.2019.03.006. Epub 2019 Mar 15. PubMed PMID: 31010617; PubMed Central PMCID: PMC6954689.</p></li><li><p class="font-bold mb-0">Cancer Stem Cell based molecular predictors of tumor recurrence in Oral squamous cell carcinoma</p><p class="mt-0">Mohanta S, Sekhar Khora S, Suresh A. Arch Oral Biol. 2019 Mar;99:92-106. doi: 10.1016/j.archoralbio.2019.01.002. Epub 2019 Jan 4. PubMed PMID: 30641296.</p></li></ol><p class="text-2xl font-bold uppercase">2018</p><ol><li><p class="font-bold mb-0">Point-of-care, smartphone-based, dual-modality, dual-view, oral cancer screening device with neural network classification for low-resource communities</p><p class="mt-0">Uthoff RD, Song B, Sunny S, Patrick S, Suresh A, Kolur T, Keerthi G, Spires O, Anbarani A, Wilder-Smith P, Kuriakose MA, Birur P, Liang R. PLoS One. 2018;13(12):e0207493. doi: 10.1371/journal.pone.0207493. eCollection 2018. PubMed PMID: 30517120; PubMed Central PMCID: PMC6281283.</p></li><li><p class="font-bold mb-0">Automatic classification of dual-modalilty, smartphone-based oral dysplasia and malignancy images using deep learning</p><p class="mt-0">Song B, Sunny S, Uthoff RD, Patrick S, Suresh A, Kolur T, Keerthi G, Anbarani A, Wilder-Smith P, Kuriakose MA, Birur P, Rodriguez JJ, Liang R Biomed Opt Express. 2018 Nov 1;9(11):5318-5329. doi: 10.1364/BOE.9.005318. eCollection 2018 Nov 1. PubMed PMID: 30460130; PubMed Central PMCID: PMC6238918.</p></li><li><p class="font-bold mb-0">Detection of High-Risk Human Papillomavirus in Oral Cavity Squamous Cell Carcinoma Using Multiple Analytes and Their Role in Patient Survival</p><p class="mt-0">Palve V, Bagwan J, Krishnan NM, Pareek M, Chandola U, Suresh A, Siddappa G, James BL, Kekatpure V, Kuriakose MA, Panda B. J Glob Oncol. 2018 Nov;4:1-33. doi: 10.1200/JGO.18.00058. PubMed PMID: 30398949; PubMed Central PMCID: PMC7010445.</p></li><li><p class="font-bold mb-0">A Novel Mobile Health Approach to Early Diagnosis of Oral Cancer</p><p class="mt-0">Birur NP, Patrick S, Bajaj S, Raghavan S, Suresh A, Sunny SP, Chigurupati R, Wilder-Smith P, Gurushanth K, Gurudath S, Rao P, Kuriakose MA. J Contemp Dent Pract. 2018 Sep 1;19(9):1122-1128. PubMed PMID: 30287715; PubMed Central PMCID: PMC6455929.</p></li><li><p class="font-bold mb-0">A minimal set of internal control genes for gene expression studies in head and neck squamous cell carcinoma</p><p class="mt-0">Palve V, Pareek M, Krishnan NM, Siddappa G, Suresh A, Kuriakose MA, Panda B. PeerJ. 2018;6:e5207. doi: 10.7717/peerj.5207. eCollection 2018. PubMed PMID: 30128175; PubMed Central PMCID: PMC6097490.</p></li><li><p class="font-bold mb-0">Proteome analysis reveals that de novo regenerated mucosa over fibula flap-reconstructed mandibles resembles mature keratinized oral mucosa</p><p class="mt-0">Kumar VV, James BL, Ruß M, Mikkat S, Suresh A, Kämmerer PW, Glocker MO Oral Oncol. 2018 Mar;78:207-215. doi: 10.1016/j.oraloncology.2018.01.017. Epub 2018 Feb 20. PubMed PMID: 29496052.</p></li><li><p class="font-bold mb-0">Chairside molecular imaging of aberrant glycosylation in subjects with suspicious oral lesions using fluorescently labeled wheat germ agglutinin</p><p class="mt-0">Baeten J, Johnson A, Sunny S, Suresh A, Birur P, Uma K, Kademani D. Head Neck. 2018 Feb;40(2):292-301. doi: 10.1002/hed.24943. Epub 2017 Sep 30. PubMed PMID: 28963821.</p></li></ol></div></div></div></section><footer class="w-full relative mt-10 footer-bg p-12"><div class="relative mx-auto bg-msmf-base p-8 z-10 flex space-x-20 items-start"><div id="get-in-touch" class="w-full"><p class="font-semibold text-white text-2xl">Get in touch</p><hr class="border-msmf-dark my-4"/><p class="text-white text-lg mt-6"><span class="font-semibold italic">Meet us:</span> <!-- -->A-Block, 8th Floor #258/A, NH Health City, Bangalore - 560 099</p><p class="text-white text-lg mt-6"><span class="font-semibold italic">Call us:</span> <!-- -->+91-807 122 2351, +91-802 780 3456</p><p class="text-white text-lg mt-6"><span class="font-semibold italic">Email us:</span> <!-- -->msmf@ms-mf.org</p><p class="text-white text-lg mt-6"><span class="font-semibold italic">Locate us:</span> <iframe src="https://www.google.com/maps/embed?pb=!1m18!1m12!1m3!1d3890.5627527677534!2d77.69266841508325!3d12.80686937193603!2m3!1f0!2f0!3f0!3m2!1i1024!2i768!4f13.1!3m3!1m2!1s0x3bae6c33ea16001d%3A0x51693da9325cf807!2sMazumdar%20Shaw%20Medical%20Center!5e0!3m2!1sen!2sin!4v1644062770890!5m2!1sen!2sin" width="400" height="200" style="margin-top:1rem;margin-bottom:0" allowfullscreen="" loading="lazy"></iframe></p></div><div id="get-connected" class="w-full"><p class="font-semibold text-white text-2xl">Get connected</p><hr class="border-msmf-dark my-4"/><div class="flex items-center justify-between"><img src="/assets/images/Common/icons8-linkedin-192.png" alt="linkedin" class="w-10 h-10"/><img src="/assets/images/Common/icons8-facebook-192.png" alt="facebook" class="w-10 h-10"/><img src="/assets/images/Common/icons8-instagram-144.png" alt="instagram" class="w-10 h-10"/><img src="/assets/images/Common/icons8-twitter-144.png" alt="twitter" class="w-10 h-10"/><img src="/assets/images/Common/icons8-medium-256.png" alt="medium" class="w-10 h-10"/><img src="/assets/images/Common/icons8-youtube-192.png" alt="youtube" class="w-10 h-10"/></div></div><div id="sitemap" class="w-full"><p class="font-semibold text-white text-2xl">Sitemap</p><hr class="border-msmf-dark my-4"/><p class="text-white text-lg mt-2 cursor-pointer">MSMF</p><p class="text-white text-lg mt-2 cursor-pointer">Home</p><p class="text-white text-lg mt-2 cursor-pointer">Incubation</p><p class="text-white text-lg mt-2 cursor-pointer">ADRC</p><p class="text-white text-lg mt-2 cursor-pointer">Philanthropy</p><p class="text-white text-lg mt-2 cursor-pointer">Research</p></div></div></footer></div></div><script id="__NEXT_DATA__" type="application/json">{"props":{"pageProps":{}},"page":"/research/research-programs/integrated-head-and-neck-oncology","query":{},"buildId":"c1L5CVtJO_lyp2yG3iKVw","nextExport":true,"autoExport":true,"isFallback":false,"scriptLoader":[]}</script></body></html>